Many clinicians acknowledge that herpes zoster (or shingles) is not something they would wish to have, but they also seem to believe it just comes and goes. This could explain the rather low rate of ...

"These data suggest that health benefits of RZV immunization may extend beyond the well-described prevention of herpes zoster and postherpetic neuralgia." HealthDay News — Two doses of recombinant ...

KOLOA, Hawaii — The ocular manifestations of herpes zoster involve a wide range of corneal disease with the estimated worldwide cost for treatment reaching $1 billion, according to a speaker.

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Valacyclovir can be beneficial for treating multiple episodes of keratitis or iritis in patients with ...

More Americans are being diagnosed with eye complications of shingles, but older adults can call the shots on whether they are protected from the painful rash that can cost them their eyesight. Among ...

NYU Langone Medical Center will lead a five-year, 60-center clinical trial to evaluate new treatment protocols for herpes zoster ophthalmicus (HZO), a form of shingles that can seriously and ...

The effectiveness of live zoster (shingles) vaccine is highest in the first year after vaccination and then wanes substantially. But it continues to provide some protection against shingles and its ...

The first vaccine for shingles in the United States — Zostavax — was approved by the US Food and Drug Administration in 2006. The landmark study, published in the The New England Journal of Medicine ...

This case is quoted, p. 78, in Dr. H. F. Damon's little book on Neurosis of the Skin, thus: "Dr. Williams, of Boston, has observed a case of inflammation of the eye from zoster frontalis. The ...

Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir. HealthDay News — One year of valacyclovir is beneficial for patients ...

In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...